Drug interactions
Ipilimumab + Selinexor
Severity: Minor
Ipilimumab and Selinexor: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Selinexor commonly causes fatigue, dizziness, confusion and other neurologic effects. Ipilimumab can rarely cause immune-related neurologic or endocrine events that present similarly, which may complicate assessment. There is no established pharmacokinetic or direct pharmacodynamic interaction.
What this interaction means in plain words
Ipilimumab and Selinexor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Ipilimumab belongs to Oncology; Selinexor belongs to Oncology.
Why it happens
No established mechanism; overlapping adverse effects may confound clinical assessment.
What to do
No dose change is needed. Monitor neurologic status and evaluate new confusion or dizziness for immune-related endocrine or neurologic causes.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ipilimumab and Selinexor, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipilimumab
Other interactions of Selinexor
- Aldesleukin + Selinexor Moderate
- Alprazolam + Selinexor Moderate
- Amitriptyline + Selinexor Moderate
- Amobarbital + Selinexor Moderate
- Aripiprazole + Selinexor Moderate
- Asenapine + Selinexor Moderate
Frequently asked questions
Can I take Ipilimumab with Selinexor?
MediHelp rates the interaction as minor. Ipilimumab and Selinexor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Selinexor commonly causes fatigue, dizziness, confusion and other neurologic effects. Ipilimumab can rarely cause immune-related neurologic or endocrine events that present similarly, which may complicate assessment. There is no established pharmacokinetic or direct pharmacodynamic interaction.
How serious is the interaction between Ipilimumab and Selinexor?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed. Monitor neurologic status and evaluate new confusion or dizziness for immune-related endocrine or neurologic causes.
What other medicines interact with Ipilimumab?
MediHelp also lists interactions of Ipilimumab with, for example, Etrasimod, Vemurafenib, Ciltacabtagene autoleucel. The full list is on the Ipilimumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
